Terms: = Colorectal cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Treatment
41 results:
1. Nuclear Softness Promotes the Metastatic Potential of Large-Nucleated colorectal cancer Cells via the erbb4-Akt1-Lamin A/C Signaling Pathway.
Li Y; Li Q; Mu L; Hu Y; Yan C; Zhao H; Mi Y; Li X; Tao D; Qin J
Int J Biol Sci; 2024; 20(7):2748-2762. PubMed ID: 38725859
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract] [Full Text] [Related]
3. Mutational analysis of microsatellite-stable gastrointestinal cancer with high tumour mutational burden: a retrospective cohort study.
Wang J; Xiu J; Farrell A; Baca Y; Arai H; Battaglin F; Kawanishi N; Soni S; Zhang W; Millstein J; Shields AF; Grothey A; Weinberg BA; Marshall JL; Lou E; Khushman M; Sohal DPS; Hall MJ; Liu T; Oberley M; Spetzler D; Korn WM; Shen L; Lenz HJ
Lancet Oncol; 2023 Feb; 24(2):151-161. PubMed ID: 36681091
[TBL] [Abstract] [Full Text] [Related]
4. The HER family as therapeutic targets in colorectal cancer.
Ye P; Wang Y; Li R; Chen W; Wan L; Cai P
Crit Rev Oncol Hematol; 2022 Jun; 174():103681. PubMed ID: 35462030
[TBL] [Abstract] [Full Text] [Related]
5. Diagnosis and treatment of ERBB2-Positive Metastatic colorectal cancer: A Review.
Strickler JH; Yoshino T; Graham RP; Siena S; Bekaii-Saab T
JAMA Oncol; 2022 May; 8(5):760-769. PubMed ID: 35238866
[TBL] [Abstract] [Full Text] [Related]
6. Anti‑HER3 monoclonal antibody exerts antitumor activity in a mouse model of colorectal adenocarcinoma.
Asano T; Ohishi T; Takei J; Nakamura T; Nanamiya R; Hosono H; Tanaka T; Sano M; Harada H; Kawada M; Kaneko MK; Kato Y
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184091
[TBL] [Abstract] [Full Text] [Related]
7. The role of erbb4 in cancer.
Segers VFM; Dugaucquier L; Feyen E; Shakeri H; De Keulenaer GW
Cell Oncol (Dordr); 2020 Jun; 43(3):335-352. PubMed ID: 32219702
[TBL] [Abstract] [Full Text] [Related]
8. Mechanistic insights into differential requirement of receptor dimerization for oncogenic activation of mutant EGFR and its clinical perspective.
Cho J
BMB Rep; 2020 Mar; 53(3):133-141. PubMed ID: 32172728
[TBL] [Abstract] [Full Text] [Related]
9. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.
Yan T; Cui H; Zhou Y; Yang B; Kong P; Zhang Y; Liu Y; Wang B; Cheng Y; Li J; Guo S; Xu E; Liu H; Cheng C; Zhang L; Chen L; Zhuang X; Qian Y; Yang J; Ma Y; Li H; Wang F; Liu J; Liu X; Su D; Wang Y; Sun R; Guo S; Li Y; Cheng X; Liu Z; Zhan Q; Cui Y
Nat Commun; 2019 Apr; 10(1):1670. PubMed ID: 30975989
[TBL] [Abstract] [Full Text] [Related]
10. Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic colorectal cancer.
Duplaquet L; Figeac M; Leprêtre F; Frandemiche C; Villenet C; Sebda S; Sarafan-Vasseur N; Bénozène M; Vinchent A; Goormachtigh G; Wicquart L; Rousseau N; Beaussire L; Truant S; Michel P; Sabourin JC; Galateau-Sallé F; Copin MC; Zalcman G; De Launoit Y; Fafeur V; Tulasne D
Mol Cancer Ther; 2019 Jun; 18(6):1137-1148. PubMed ID: 30926633
[TBL] [Abstract] [Full Text] [Related]
11. Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients.
Gao XH; Yu GY; Hong YG; Lian W; Chouhan H; Xu Y; Liu LJ; Bai CG; Zhang W
Int J Clin Oncol; 2019 Feb; 24(2):141-152. PubMed ID: 30612269
[TBL] [Abstract] [Full Text] [Related]
12. The significance of tumor budding in T1 colorectal carcinoma: the most reliable predictor of lymph node metastasis especially in endoscopically resected T1 colorectal carcinoma.
Lee SJ; Kim A; Kim YK; Park WY; Kim HS; Jo HJ; Oh N; Song GA; Park DY
Hum Pathol; 2018 Aug; 78():8-17. PubMed ID: 29447923
[TBL] [Abstract] [Full Text] [Related]
13. miR‑1273g‑3p promotes proliferation, migration and invasion of LoVo cells via cannabinoid receptor 1 through activation of erbb4/PIK3R3/mTOR/S6K2 signaling pathway.
Li M; Qian X; Zhu M; Li A; Fang M; Zhu Y; Zhang J
Mol Med Rep; 2018 Mar; 17(3):4619-4626. PubMed ID: 29328379
[TBL] [Abstract] [Full Text] [Related]
14. Neratinib: First Global Approval.
Deeks ED
Drugs; 2017 Oct; 77(15):1695-1704. PubMed ID: 28884417
[TBL] [Abstract] [Full Text] [Related]
15. Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats.
Van Sebille YZA; Gibson RJ; Wardill HR; Secombe KR; Ball IA; Keefe DMK; Finnie JW; Bowen JM
Int J Cancer; 2017 Jun; 140(12):2820-2829. PubMed ID: 28316082
[TBL] [Abstract] [Full Text] [Related]
16. Preclinical and clinical studies on afatinib in monotherapy and in combination regimens: Potential impact in colorectal cancer.
De Pauw I; Wouters A; Van den Bossche J; Peeters M; Pauwels P; Deschoolmeester V; Vermorken JB; Lardon F
Pharmacol Ther; 2016 Oct; 166():71-83. PubMed ID: 27373506
[TBL] [Abstract] [Full Text] [Related]
17. Mutations in genes encoding PI3K-AKT and MAPK signaling define anogenital papillary hidradenoma.
Pfarr N; Sinn HP; Klauschen F; Flechtenmacher C; Bockmayr M; Ridinger K; von Winterfeld M; Warth A; Lorenz K; Budczies J; Penzel R; Lennerz JK; Endris V; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2016 Feb; 55(2):113-9. PubMed ID: 26493284
[TBL] [Abstract] [Full Text] [Related]
18. Inter- and intra-tumor profiling of multi-regional colon cancer and metastasis.
Kogita A; Yoshioka Y; Sakai K; Togashi Y; Sogabe S; Nakai T; Okuno K; Nishio K
Biochem Biophys Res Commun; 2015 Feb; 458(1):52-6. PubMed ID: 25623536
[TBL] [Abstract] [Full Text] [Related]
19. Gene expression markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance).
Cushman SM; Jiang C; Hatch AJ; Shterev I; Sibley AB; Niedzwiecki D; Venook AP; Owzar K; Hurwitz HI; Nixon AB
Clin Cancer Res; 2015 Mar; 21(5):1078-86. PubMed ID: 25520391
[TBL] [Abstract] [Full Text] [Related]
20. Irreversible multitargeted ErbB family inhibitors for therapy of lung and breast cancer.
Subramaniam D; He AR; Hwang J; Deeken J; Pishvaian M; Hartley ML; Marshall JL
Curr Cancer Drug Targets; 2015; 14(9):775-93. PubMed ID: 25435079
[TBL] [Abstract] [Full Text] [Related]
[Next]
